Closed System Drug Transfer Device Market Research Report - Forecast till 2032

Closed System Drug Transfer Device (CSTD) Market Research Report Information By Type (Barrier Type and Filtration Type) by Closing Mechanism (Push to Turn System, Color-to-Color Alignment System, Leur Lock Systems, and Others), by Component (Vial Access Devices, Syringe Safety Devices, Bag/Infusion Set Devices, and Others), by Technology (Compartmentalize Devices, Diaphragm-based Devices, and Air Filtration Devices) by End User (Hospitals & Clinics, Specialty Centers, and Others), by Region (North America, Europe, Asia-Pacific, and Rest of

ID: MRFR/HC/6264-CR | 138 Pages | Author: Rahul Gotadki | March 2024         

Closed System Drug Transfer Device Market Speak to Analyst Request a Free Sample

Global Closed System Drug Transfer Device (CSTD) Market Overview


Closed System Drug Transfer Device (CSTD) Market size was valued at USD 0.73 billion in 2022. The Closed System Drug Transfer Device (CSTD) Market industry is projected to grow from USD 0.85 Billion in 2023 to USD 3.63 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 17.47% during the forecast period (2023 - 2032). The increasing use of hazardous drugs, oncology services, and home healthcare are increasing the demand for CSTDs, and stringent regulatory requirements within the healthcare industry are driving market growth.


Closed System Drug Transfer Device (CSTD) Market


Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review


Closed System Drug Transfer Device (CSTD) Market Trends



  • The increasing use of hazardous drugs boosts market growth.


The escalating utilization of hazardous drugs within the healthcare sector stands as a compelling driver significantly shaping the global healthcare landscape. According to the Centers for Disease Control and Prevention, generally, about 8 million US healthcare personnel, including pharmacy and nursing staff, physicians, operating room workers, environmental services workers, workers in research laboratories, veterinary care workers, and shipping and receiving personnel, are potentially exposed to hazardous drugs.


Furthermore, the stringent regulatory landscape set forth by healthcare authorities, such as the U.S. Food and Drug Administration (FDA), has mandated the obligatory use of CSTDs during the intricate processes of hazardous drug preparation and administration. This regulatory framework underscores the critical role that CSTDs play in minimizing exposure risks, reinforcing their market presence as a non-negotiable component of modern healthcare practice. Moreover, this heightened awareness of safety protocols, coupled with the ever-expanding prevalence of chronic diseases, further accelerates the integration of CSTDs into the standard operating procedures of healthcare facilities worldwide.


Closed System Drug Transfer Device (CSTD) Market Segment Insights


Closed System Drug Transfer Device (CSTD) Type Insights


The Closed System Drug Transfer Device (CSTD) Market segmentation, based on type, includes barrier type and filtration type. The barrier type segment held the majority share in 2022 in the Closed System Drug Transfer Device (CSTD) Market revenue. This is due to the growing geriatric population and rising awareness of CSTD devices. Moreover, the barrier-type devices block the accidental release of drugs into the environment and prevent the contamination caused due to the impurities in the outer environment.


CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET SIZE, BY TYPE, 2022 & 2032 (USD Billion)


CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET SIZE, BY TYPE, 2022 & 2032


Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review


Closed System Drug Transfer Device (CSTD) Closing Mechanism Insights


The Closed System Drug Transfer Device (CSTD) Market segmentation is based on closing mechanism that include push to turn system, color-to-color alignment system, leur lock systems, and others. The push to turn system segment has dominated the market in 2022 and leur lock systems segment is projected to be the fastest-growing segment during the forecast period, 2023-2032. This is attributed to the increasing hospital admissions and expanding number of surgical procedures. Furthermore, the increasing number of cancer incidences globally and the need for such devices to reduce the risk associated with handling hazardous drugs is propelling the market growth for this segment.


March 2021: The U.S. Food and Drug Administration has approved Yukon Medical's (US) Arisure closed system transfer device (CSTD) under the ONB product classification.


Closed System Drug Transfer Device (CSTD) Component Insights


The Closed System Drug Transfer Device (CSTD) Market segmentation is based on component that include vial access devices, syringe safety devices, bag/infusion set devices, and others. The vial access devices segment has dominated the market in 2022 and is projected to be the fastest-growing segment during the forecast period, 2023-2032. This is attributed to the increasing prevalence of cancer and ease of use. Additionally, vial access devices are available with different properties such as needle-free that automatically equalizes vial pressure by reducing aerosols, prevents vaporization and leakage of drugs, and releases the desired volume of drugs from the device.


Closed System Drug Transfer Device (CSTD) Technology Insights


The Closed System Drug Transfer Device (CSTD) Market segmentation is based on technology that includes compartmentalize devices, diaphragm-based devices, and air filtration devices. The diaphragm-based devices segment has dominated the market in 2022 and compartmentalize devices is projected to be the fastest-growing segment during the forecast period, 2023-2032. This is attributed to growing technological advancement and growing awareness about the availability of products. Additionally, diaphragm-based devices are employed extensively during pressure equalization. The technique prevents the spread of dangerous vapors and protects against harmful exposure.


Closed System Drug Transfer Device (CSTD) End User Insights


The Closed System Drug Transfer Device (CSTD) Market segmentation is based on end user that includes hospitals & clinics, specialty centers, and others. The hospitals & clinics segment has dominated the market in 2022 and the specialty centers segment is projected to be the fastest-growing segment during the forecast period, 2023-2032. This is due to the high adoption of CSTD systems is due to the high purchasing power of big hospitals and growing healthcare infrastructure, and high purchasing power, and the growing awareness and adoption of CSTD devices for the delivery of many diseases as well as the increasing number of patients suffering from chronic diseases.


March 2022: Simplivia Healthcare, Ltd. (Israel) launched Chemfort, a closed-system drug transfer device that reduces the risk of exposure for healthcare professionals. This air-cleaning technology has been qualified as the most efficacious and user-friendly.


Closed System Drug Transfer Device (CSTD) Regional Insights


By Region, the study segments the market into North America, Europe, Asia-Pacific, and the Rest of the World. The North America closed system drug transfer device (CSTD) market accounted for the largest market share in 2022. This is due to the increasing prevalence of cancer cases and the strong research and development infrastructure in the North American region. For instance, In the United States in 2020, there were 1,603,844 new cancer cases reported and 602,347 cancer deaths. There were 403 new cancer cases reported for every 100,000 people, and 144 people died from cancer. Moreover, the presence of major market players, high awareness about CSTD products among end users, and recent technological advancements in the region are likely to enhance the growth of the CSTD market in North America.


Further, the major countries studied are the U.S., Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, and South Korea.


Figure 3: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET SIZE, BY REGION 2022 & 2032 (USD Billion)


CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET SIZE, BY REGION 2022 & 2032


Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review


Europe closed system drug transfer device (CSTD) market accounts for the second-largest market share due to the highly developed healthcare industry, prominent research, and development infrastructure, and accessibility of CSTD products in the region. Furthermore, Germany closed system drug transfer device (CSTD) market was attributed to hold the largest market share, and France closed system drug transfer device (CSTD) market is expected to fastest-growing market in the European region.


The Asia-Pacific closed system drug transfer device (CSTD) market is expected to grow at a significant share from 2023 to 2032. This is due to the increasing number of new vendors involved in the drug-device system, as there are many niche market players who are trying to leverage the market share. Moreover, China closed system drug transfer device (CSTD) market is expected to hold the largest market share, and India closed system drug transfer device (CSTD) market is expected fastest-growing market in the Asia-Pacific region.


Furthermore, in India, one in every nine people will develop cancer during their lifetime. Lung and breast cancers were the most common cancer sites in men and women, respectively. Many patients suffering from cancer and in need of delivery are anticipated to increase the lucrativeness of the region in the closed system drug transfer device (CSTD) market.


The Rest of the World is segmented into the Middle East, Africa, and Latin America. The closed system drug transfer device (CSTD) market in the above-mentioned regions is likely to witness growth due to technological advancement in the delivery of effective healthcare services and growing healthcare costs. Moreover, the increasing burden of cancer in Africa also influences the market.


Closed System Drug Transfer Device (CSTD) Key Market Players & Competitive Insights


The Closed System Drug Transfer Device (CSTD) Market is characterized by the presence of many global, regional, and local vendors. Developments in the healthcare industry and growing research and development make the closed system drug transfer device (CSTD) market lucrative. To expand their reach and optimize their operational costs, the major players focus on obtaining regulatory authorizations from government agencies for their products and emphasize acquisitions and product launches to gain a substantial market share. The market comprises tier-1, tier-2, and local players. The tier-1 and tier-2 players have reach across the globe with diverse product portfolios. Companies such as Becton, Dickinson and Company (US), B. Braun SE (Germany), Epic Medical (Singapore), and Simplivia Healthcare, Ltd. (Israel) dominate the Closed System Drug Transfer Device (CSTD) Market due to product differentiation, financial stability, strategic developments, and diversified regional presence. The players are focused on investing in research and development. Furthermore, they adopt strategic growth initiatives, such as expansion, product launches, joint ventures, and partnerships, to strengthen their market position and capture a large customer base.


One of the primary business strategies adopted by manufacturers in the global closed system drug transfer device (CSTD) industry to benefit clients and expand the closed system drug transfer device (CSTD) market sector is to manufacture locally to reduce operating costs.


B.Braun (Germany) is a healthcare supplier and manufacturer that offers its products to hospitals, surgical units, private practices (medical care and doctors' offices), and extracorporeal blood treatments. It offers products in the following categories: clinical nutrition, urinary care, infection prevention, infusion therapy, diabetes care, neurosurgery, extracorporeal blood treatment, intravenous (IV) drugs, orthopedics, spine care, and wound care. The company offers approximately 5,000 products within the above-mentioned product category. Geographically, it operates in 64 countries in the region, including the Americas, Europe, Asia-Pacific, and the Middle East & Africa. For instance, in December 2021, B. Braun Medical Inc. (US), a subsidiary of B. Braun SE, launched OnGuard 2 in the US with upgraded materials and enhanced features to improve its usability. Moreover, OnGuard is designed to make OnGuard 2 easy to operate and adopt in healthcare practices.


Also, Simplivia (Israel) is a worldwide leader in the design, manufacturing, and delivery of drug delivery solutions. It is involved in advancing medical solutions for drug delivery to ensure the safety of medical professionals, such as nurses, pharmacists, and veterinarians. It operates in more than 33 countries across the region, namely the Americas, Europe, Asia-Pacific, and the Middle East & Africa. It offers a broad and innovative product pipeline that is Food and Drug Administration (US) and CE-approved. Furthermore, it sells its products, which are the highest International Organization for Standardization (ISO) across the globe. It has a presence in regions namely the Americas, Europe, Asia-Pacific, and the Middle East.


Key Companies in the Closed System Drug Transfer Device (CSTD) Market include



  • Becton, Dickinson and Company (US)

  • BRAUN SE (Germany)

  • Epic Medical (Singapore)

  • Simplivia Healthcare, Ltd. (Israel)

  • JMS Co. Ltd (Japan)

  • Equashield (US)

  • ICU Medical, Inc (US)

  • Yukon Medical (US)

  • Caragen Ltd (Ireland)

  • Corvida Medical (US)


Closed System Drug Transfer Device (CSTD) Industry Developments


October 2022: Equashield (US) collaborated with Nordic Capital (US). Through this collaboration, Nordic Capital will assist Equashield in achieving its strategic goal of becoming the world leader in compounding technologies as well as accelerating its growth aspirations.


April 2019: Equashield (US) and Leaf Medical LTD (UK) have expanded the partnership to offer their manual and automatic Closed System Transfer Device (CSTD) solutions for the safe formulation and administration of hazardous medications.


Closed System Drug Transfer Device (CSTD) Market Segmentation


Closed System Drug Transfer Device (CSTD) Type Outlook



Closed System Drug Transfer Device (CSTD) Closing Mechanism Outlook



  • Push to Turn System

  • Color-to-Color Alignment System

  • Leur Lock Systems

  • Others


Closed System Drug Transfer Device (CSTD) Component Outlook



  • Vial Access Devices

  • Syringe Safety Devices

  • Bag/Infusion Set Devices

  • Others


Closed System Drug Transfer Device (CSTD) Technology Outlook



  • Compartmentalize Devices

  • Diaphragm-based Devices

  • Air Filtration Devices


Closed System Drug Transfer Device (CSTD) End User Outlook



  • Hospitals & Clinics

  • Specialty Centers

  • Others


Closed System Drug Transfer Device (CSTD) Regional Outlook



  • North America

    • US

    • Canada



  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe



  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • Rest of the World

    • Middle East

    • Africa

    • Latin America



Report Scope:

Report Attribute/Metric Details
Market Size 2022 USD 0.73 billion
Market Size 2023 USD 0.85 billion
Market Size 2032 USD 3.63 billion
Compound Annual Growth Rate (CAGR) 17.47% (2023-2032)
Base Year 2022
Forecast Period 2023-2032
Historical Data 2019 to 2021
Forecast Units Value (USD Billion)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered Type, Closing Mechanism, Component, Technology, and End User
Geographies Covered North America, Europe, Asia Pacific, and the Rest of the World
Countries Covered The U.S., Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, and South Korea.
Key Companies Profiled Becton, Dickinson and Company (US), B. BRAUN SE (Germany), Epic Medical (Singapore), Simplivia Healthcare, Ltd. (Israel), JMS Co.Ltd (Japan), Equashield (US), ICU Medical, Inc (US), Yukon Medical (US ), Caragen Ltd (Ireland), and Corvida Medical (US)
Key Market Opportunities ·       Increasing investment in healthcare infrastructure presents a substantial opportunity for the market
Key Market Dynamics ·       Increasing Use of Hazardous Drugs ·       Oncology services and home healthcare are increasing the demand for CSTDS. ·       Stringent regulatory requirements within the healthcare industry




Frequently Asked Questions (FAQ) :

The Closed System Drug Transfer Device (CSTD) Market is anticipated to reach 3.63 billion at a CAGR of 17.47% during the forecast period of 2023-2032.

The US held over 83.02% share of the North America market for the closed system drug transfer device (CSTD) market during the forecast period of 2023-2032.

The closed system drug transfer device (CSTD) market is expected to grow at a 17.47% CAGR during the forecast period from 2023 to 2032.

The North American region market held the largest market share in the Closed system drug transfer device (CSTD) market.

The key players include Becton, Dickinson and Company (US), B. BRAUN SE (Germany), Epic Medical (Singapore), Simplivia Healthcare, Ltd. (Israel), JMS Co. Ltd (Japan), Equashield (US), ICU Medical, Inc (US), Yukon Medical (US), Caragen Ltd (Ireland), and Corvida Medical (US).

The barrier type segment was estimated to lead the closed system drug transfer device (CSTD) market.

The hospitals & clinics segment is attributed to having the largest market share based on end user.

Key Questions Answered

  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Request Free Sample

Why Choose Market Research Future?

  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.
Speak to Analyst
Leading companies partner with us for data-driven Insights.
Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response
Invalid